At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting‑edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together.TheMedical Director, Oncology Clinical Developmentwill report to the Executive Medical Director / Clinical Development Lead (CDL), Oncology Clinical Development. This position will support our growing oncology portfolio for the treatment of hematological malignancies. The Medical Director will have the opportunity to work across early‑to‑late stage development and in partnership with a multi‑disciplinary team of oncology drug developers.An on‑site office presence for a minimum of two days a week is required in one of GSK’s UK (London or Stevenage), US (Greater Philadelphia or Waltham), Canada (Mississauga), Switzerland (Zug) or Poland (Warsaw) campuses.Key ResponsibilitiesCollaborate with physicians, scientists, regulatory professionals, biostatisticians, executive staff, and others in a complex matrix environment to develop and execute phase 1‑3 interventional clinical trialsUse medical expertise to contribute to the end‑to‑end (protocol concept to final study report) and timely delivery of clinical trials while ensuring patient safety, scientific integrity, and consistency with the clinical development strategy; demonstrate ability to incorporate global considerations into decision makingEnsure high‑quality protocol development aligned with the early Clinical Development Plan to effectively determine a medicine’s potential efficacy, safety profile, key areas of product differentiation and value to patient in the shortest possible timeframeAssume medical responsibility for early phase clinical trials with active participation in real‑time medical monitoring, including patient eligibility assessment, study design questions,



and addressing urgent safety questions (with inclusion of Safety/PV as relevant)Assume responsibility for medical review of clinical trial data, both directly and/or via oversight of delegated medical reviewReview and monitor safety data in collaboration with pharmacovigilance group for active clinical studiesInterpret and summarize study results consistent with objectives to define safety, efficacy, pharmacokinetic/pharmacodynamic, and patient reported outcomes, and applicability of data to the targeted patient populationParticipate in the authoring of clinical study reports and regulatory documents and collaborate with colleagues in Regulatory Affairs, CMC, Toxicology, Research, and Pharmacology to respond to health authority and ethics committee queriesCollaborate with Principal Investigators in the authoring of publications (abstracts, posters, manuscripts) associated with clinical dataNetwork extensively to develop long‑term strategic partnerships with thought leaders both internally and externally, in support of GSK’s visionServe as a core member of the Early Development Team for one or more assets in developmentParticipate in Oncology Clinical Development‑wide initiatives and workstreams as appropriateWhy You?Basic QualificationsBasic QualificationsMedical degree with board certification/eligibility or registration qualifications in medical oncology, hematology or hematology/oncologyExperience in the pharmaceutical/biotechnology industry, clinical academic medicine, or clinical medical practice, in the field of hematology and/or oncologyOncology clinical drug development experience in the conduct of clinical trials (investigator‑initiated, company‑sponsored or cooperative group trials)



and their subsequent publicationsPreferred QualificationsMD / PhD preferredClinical experience of managing patients with hematological malignanciesOncology clinical research and drug development experience focused on hematological malignancies, including multiple myelomaSound understanding of biological mechanisms, clinical strategy, scientific interpretation of disease and target‑based literatureRobust knowledge of preclinical/mechanistic translational research, disease‑specific research priorities, competitor landscape, and treatment guidelines evolutionSalary and BenefitsFor the United States, the annual base salary for new hires in this position ranges $222,750 to $371,250. The US salary ranges take into account a number of factors including work location within the US market, the candidate’s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share‑based long‑term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave. Polish Salary Range: EUR 455,250 to EUR 758,750. The annual gross base salary range for new hires in this position is listed above for each applicable location. In addition, this position may offer an annual bonus and eligibility to participate in our share‑based long‑term incentive program which is dependent on the level of the role. More detailed information on the total perks package will be supplied during the recruitment process. Offers are typically made within the advertised range based on the candidate’s skills, experience and qualifications, with the upper end generally reserved for highly experienced candidates or other exceptional circumstances aligned with these criteria.GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.#J-18808-Ljbffr

📌 Medical Director, Oncology Clinical Development - $222,750 - $300,000 A Year (Winnipeg)
🏢 GSK
📍 Winnipeg